Auto Injectors Market

Auto Injectors Market

Auto-Injectors Market Forecasts to 2030 - Global Analysis By Type (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Therapy (Anaphylaxis, Asthma, Diabetes and Other Therapies), Type of Molecule, Distribution Channel, End User and By Geography

4.5 (92 reviews)
4.5 (92 reviews)
Published: 2023 ID: SMRC23970

This report covers the impact of COVID-19 on this global market

Years Covered


Estimated Year Value (2023)

US $2.03 BN

Projected Year Value (2030)

US $7.94 BN

CAGR (2023-2030)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific

According to Stratistics MRC, the Global Auto-Injectors Market is accounted for $2.03 billion in 2023 and is expected to reach $7.94 billion by 2030 growing at a CAGR of 21.5% during the forecast period. An auto-injector is a syringe with a needle that has been pre-charged with a dosage of drugs and is spring-charged. When a sliding motion is used to press the device into the body, the system activates and delivers a precise dosage of a medication. The self-administration of epinephrine by migraineurs or for medical and emergency treatments is frequently done with the aid of auto-injectors.

According to the National Health Interview Survey (NHIS), nearly 52% of the adult population in the US is diagnosed with at least one chronic condition, such as asthma, diabetes, and hypertension.

Market Dynamics:


Increasing prevalence of chronic diseases

The demand for auto-injectors has also increased as chronic diseases like diabetes, rheumatoid arthritis, and multiple sclerosis are becoming more common. Auto-injectors provide a secure and reliable way to administer these medications, which are frequently injected regularly to treat these conditions. For instance, The International Diabetes Federation (IDF) estimates that 537 million people worldwide had diabetes in 2021, and that number is expected to rise sharply in the years to come. Since the majority live in low- and middle-income countries, diabetes directly causes 1.5 million deaths annually. Moreover, market statistics for auto-injectors will increase due to the rising significance of preventive care in both developed and developing economies.


Availability of alternative modes of drug delivery

Traditionally, injectable medications have been delivered with a syringe and are painful to receive. This is why other administration methods like oral, nasal, and topical routes are gaining more attention from both patients and healthcare professionals. Additionally, owing to technological developments, needle-free injectors have been created, and a lot of drugs are administered frequently for conditions like growth hormone deficiency, rheumatoid arthritis, and diabetes, among others. As a result, patients with these conditions may develop needle phobia as a result of repeated injections, which would encourage them to switch to alternative drug delivery methods.


Rising shift of therapy to home settings

Home care settings are receiving more attention worldwide. This is supported by improvements in medical technology, significant financial savings over hospital-based treatments, and changing patient preferences. Additionally, the development of auto-injectors with technological advancements like audio-visual cues for easy handling and administration, connectivity for better assistance, and large dose and volume devices for less frequent drug administration are all supporting the adoption of auto-injectors in home care settings, which consequently offers opportunities in the market.


Regulatory challenges

Stringent regulatory requirements, especially in the healthcare and pharmaceutical sectors, can pose significant challenges. Changes in regulations, compliance issues, and lengthy approval processes can delay product launches. As a result, it increases costs, which might impede market entry and growth.

Covid-19 Impact:

The COVID-19 outbreak has interfered with a number of healthcare operations, but the auto-injector market is still experiencing strong revenue growth. An additional driver of market demand is the rising incidence rate of various respiratory complications among COVID-19 patients. Auto-injectors are self-administration drug devices that contain a range of medications for the treatment of various illnesses, including rheumatoid arthritis, diabetes, and others. Additionally, auto-injectors aid in the administration of a regular dose of medication, which became very popular during the COVID-19 pandemic when healthcare facilities were overrun with COVID patients.

The rheumatoid arthritis segment is expected to be the largest during the forecast period

Over the forecast period, rheumatoid arthritis is anticipated to hold a sizable market share. An autoimmune condition called rheumatoid arthritis (RA) occurs when the body's immune system attacks the joints, inflaming the synovium and resulting in swelling and pain in the joints and the surrounding tissues. Women are more likely to have arthritis than men, and it primarily affects the elderly. For instance, According to the United Nations World Population Prospects 2020 report, there are currently 727 million people in the world who are 65 or older, and by the year 2050, this number is projected to more than double. As the prevalence of arthritis among the elderly population rises, this market segment will expand over the forecast period.

The homecare settings segment is expected to have the highest CAGR during the forecast period

During the anticipated timeframe, the segment for homecare settings is predicted to have the highest CAGR. The use of auto-injectors is anticipated to rise in response to the rising demand for healthcare services provided at home. Numerous medications, including DMARDs, biologics, and vaccines, can be administered using these devices. Moreover, the demand for auto-injectors in homecare settings will therefore be driven by the growing sophistication of healthcare infrastructure and accessibility, which is assisting in the market's expansion.

Region with largest share:

Throughout the forecast period, North America is anticipated to account for the largest market share for disposable auto-injectors. The market in the region is boosted by factors like early adoption of technologically advanced products and product approvals, as well as an increase in the prevalence of chronic diseases. In addition, the United States market is growing as a result of rising technological advancements, increased entry of new players, and quick adoption of advanced products. The North American region is therefore anticipated to experience growth as a result of the aforementioned factors.

Region with highest CAGR:

Due to factors like the rising prevalence of diabetes and anaphylaxis brought on by food allergies in nations like India, China, Japan, Singapore, and Australia, Asia Pacific is predicted to grow at the highest CAGR. In numerous Asian nations, diabetes is a major health concern. As a result, the use of insulin auto-injectors has increased to assist people with diabetes in effectively managing their condition. Due to the aforementioned factors, the Asia-Pacific region offers significant potential for growth in the auto-injector market.

Key players in the market

Some of the key players in Auto-Injectors Market include AbbVie Inc, Amgen Inc., Antares Pharma, Bayer AG, Becton, Dickinson and Company, Biogen, Eli Lilly and Company, F. Hoffmann La Roche Ltd., GlaxoSmithKline plc, Halozyme Therapeutics Inc., Johnson & Johnson, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., Recipharm AB, Teva Pharmaceutical and Ypsomed.

Key Developments:

In October 2023, AbbVie announced that it has exercised its exclusive right and completed the acquisition of Mitokinin, a discovery-stage biotechnology company developing a potentially first-in-class disease-modifying treatment for Parkinson's Disease (PD). Mitokinin's lead compound, a selective PINK1 activator, is designed to address mitochondrial dysfunction that is believed to be a major contributing factor to Parkinson's disease pathogenesis and progression.

In October 2023, Amgen announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.

Types Covered:
• Disposable
• Reusable

Route of Administration Covered:
• Subcutaneous
• Intramuscular

Therapies Covered:
• Anaphylaxis
• Asthma
• Diabetes
• Hormone Therapy
• Migraine
• Multiple Sclerosis
• Oncology
• Rheumatoid Arthritis
• Other Therapies

Type of Molecules Covered:
• Monoclonal Antibody
• Peptide
• Protein
• Small Molecule

Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

End Users Covered:
• Home Care Settings
• Hospitals & Clinics
• Ambulatory Care Settings

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Auto-Injectors Market, By Type
5.1 Introduction
5.2 Disposable
5.3 Reusable
5.3.1 Prefilled Auto-injectors
5.3.2 Empty Auto-injectors

6 Global Auto-Injectors Market, By Route of Administration
6.1 Introduction
6.2 Subcutaneous
6.3 Intramuscular

7 Global Auto-Injectors Market, By Therapy
7.1 Introduction
7.2 Anaphylaxis
7.3 Asthma
7.4 Diabetes
7.5 Hormone Therapy
7.6 Migraine
7.7 Multiple Sclerosis
7.8 Oncology
7.9 Rheumatoid Arthritis
7.10 Other Therapies

8 Global Auto-Injectors Market, By Type of Molecule
8.1 Introduction
8.2 Monoclonal Antibody
8.3 Peptide
8.4 Protein
8.5 Small Molecule

9 Global Auto-Injectors Market, By Distribution Channel
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Retail Pharmacies
9.4 Online Pharmacies

10 Global Auto-Injectors Market, By End User
10.1 Introduction
10.2 Home Care Settings
10.3 Hospitals & Clinics
10.4 Ambulatory Care Settings

11 Global Auto-Injectors Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 AbbVie Inc
13.2 Amgen Inc.
13.3 Antares Pharma
13.4 Bayer AG
13.5 Becton, Dickinson and Company
13.6 Biogen
13.7 Eli Lilly and Company
13.8 F. Hoffmann La Roche Ltd.
13.9 GlaxoSmithKline plc
13.10 Halozyme Therapeutics Inc.
13.11 Johnson & Johnson
13.12 medmix Ltd.
13.13 Merck KGaA
13.14 Owen Mumford Ltd.
13.15 Pfizer Inc.
13.16 Recipharm AB
13.17 Teva Pharmaceutical
13.18 Ypsomed

List of Tables
1 Global Auto-Injectors Market Outlook, By Region (2021-2030) ($MN)
2 Global Auto-Injectors Market Outlook, By Type (2021-2030) ($MN)
3 Global Auto-Injectors Market Outlook, By Disposable (2021-2030) ($MN)
4 Global Auto-Injectors Market Outlook, By Reusable (2021-2030) ($MN)
5 Global Auto-Injectors Market Outlook, By Prefilled Auto-injectors (2021-2030) ($MN)
6 Global Auto-Injectors Market Outlook, By Empty Auto-injectors (2021-2030) ($MN)
7 Global Auto-Injectors Market Outlook, By Route of Administration (2021-2030) ($MN)
8 Global Auto-Injectors Market Outlook, By Subcutaneous (2021-2030) ($MN)
9 Global Auto-Injectors Market Outlook, By Intramuscular (2021-2030) ($MN)
10 Global Auto-Injectors Market Outlook, By Therapy (2021-2030) ($MN)
11 Global Auto-Injectors Market Outlook, By Anaphylaxis (2021-2030) ($MN)
12 Global Auto-Injectors Market Outlook, By Asthma (2021-2030) ($MN)
13 Global Auto-Injectors Market Outlook, By Diabetes (2021-2030) ($MN)
14 Global Auto-Injectors Market Outlook, By Hormone Therapy (2021-2030) ($MN)
15 Global Auto-Injectors Market Outlook, By Migraine (2021-2030) ($MN)
16 Global Auto-Injectors Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
17 Global Auto-Injectors Market Outlook, By Oncology (2021-2030) ($MN)
18 Global Auto-Injectors Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
19 Global Auto-Injectors Market Outlook, By Other Therapies (2021-2030) ($MN)
20 Global Auto-Injectors Market Outlook, By Type of Molecule (2021-2030) ($MN)
21 Global Auto-Injectors Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
22 Global Auto-Injectors Market Outlook, By Peptide (2021-2030) ($MN)
23 Global Auto-Injectors Market Outlook, By Protein (2021-2030) ($MN)
24 Global Auto-Injectors Market Outlook, By Small Molecule (2021-2030) ($MN)
25 Global Auto-Injectors Market Outlook, By Distribution Channel (2021-2030) ($MN)
26 Global Auto-Injectors Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
27 Global Auto-Injectors Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
28 Global Auto-Injectors Market Outlook, By Online Pharmacies (2021-2030) ($MN)
29 Global Auto-Injectors Market Outlook, By End User (2021-2030) ($MN)
30 Global Auto-Injectors Market Outlook, By Home Care Settings (2021-2030) ($MN)
31 Global Auto-Injectors Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
32 Global Auto-Injectors Market Outlook, By Ambulatory Care Settings (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

List of Figures
Figure 1 Global Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 2 North America Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 3 US Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 4 Canada Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 6 Europe Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 7 Germany Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 8 UK Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 9 Italy Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 10 France Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 11 Spain Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 14 Japan Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 15 China Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 16 India Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 17 Australia Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 21 South America Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 24 Chile Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 28 UAE Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Auto-Injectors Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Auto-Injectors Market Outlook (2021-2030) ($MN)


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.